A Phase III Study of Efficacy, Safety and Tolerability of Chronocort Compared With Standard Glucocorticoid Replacement Therapy in the Treatment of Congenital Adrenal Hyperplasia
Phase of Trial: Phase III
Latest Information Update: 21 Aug 2017
At a glance
- Drugs Hydrocortisone (Primary)
- Indications Congenital adrenal hyperplasia
- Focus Registrational; Therapeutic Use
- Sponsors Diurnal
- 31 Jul 2017 Planned number of patients changed from 110 to 120.
- 13 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Apr 2018.
- 13 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Apr 2018.